Related Experiment Video
Updated: May 31, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease
Sundararaman Swaminathan1, Sudhir V Shah
1Division of Nephrology, University of Arkansas for Medical Sciences and Central Arkansas Veteran Affairs Health System, Little Rock, Arkansas 72205, USA. sswaminathan@uams.edu
Abstract:
A substantial body of evidence has accumulated linking an increased incidence of cardiovascular disease in patients with acute kidney injury (AKI), chronic kidney disease (CKD), and end-stage renal disease (ESRD). A multitude of novel risk factors related to decreased kidney function might interact with the renal and systemic immune systems involved in renal injury and repair to participate in accelerated atherogenesis (Immune inflammation-Renal injury-Atherosclerosis--the IRA Paradigm). In this review, we will discuss several of these novel risk factors and present the potential for the role of the immune-inflammatory system in accelerated atherosclerosis of kidney disease.
Insights
Kidney disease, including acute kidney injury (AKI) and chronic kidney disease (CKD), significantly increases cardiovascular disease risk. Novel factors may drive accelerated atherosclerosis through immune-inflammatory pathways, impacting kidney health and heart disease.
Area of Science:
- Nephrology
- Cardiology
- Immunology
- Atherosclerosis Research
Background:
- Growing evidence links kidney diseases (acute kidney injury, chronic kidney disease, end-stage renal disease) with a higher incidence of cardiovascular disease.
- The interplay between kidney function, immune responses, and cardiovascular health is increasingly recognized as a critical area of research.
- Accelerated atherosclerosis is a major complication in patients with kidney disease.
Purpose of the Study:
- To review novel risk factors associated with decreased kidney function.
- To explore the role of the immune-inflammatory system in accelerated atherosclerosis within the context of kidney disease.
- To present the Immune inflammation-Renal injury-Atherosclerosis (IRA) Paradigm.
Main Methods:
- Literature review of existing evidence on kidney disease and cardiovascular disease.
- Analysis of novel risk factors contributing to atherosclerosis in renal impairment.
- Discussion of the immune-inflammatory mechanisms underlying the IRA Paradigm.
Main Results:
- Novel risk factors associated with reduced kidney function are identified.
- The immune-inflammatory system plays a significant role in the accelerated development of atherosclerosis in kidney disease patients.
- The IRA Paradigm provides a framework for understanding this complex relationship.
Conclusions:
- Kidney disease is strongly associated with increased cardiovascular disease risk.
- Immune-inflammatory pathways are central to accelerated atherogenesis in patients with renal impairment.
- Further research into the IRA Paradigm may reveal new therapeutic targets for cardiovascular protection in kidney disease.
Related Concept Videos
Diabetic Nephropathy
Atherosclerosis I: Introduction
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations
